Valsartan
What is Valsartan?
Valsartan (CAS 137862-53-4), also known as VAL489, is an angiotensin II receptor antagonist used as an active pharmaceutical ingredient in the treatment of hypertension and heart failure.
Where is Valsartan used?
- Cardiovascular drug formulations: core API
- Oral solid dosage forms such as tablets and capsules for antihypertensive therapy: primary active ingredient
- Combination products with hydrochlorothiazide or amlodipine
- Generic drug production: key API for formulation development and bioequivalence testing
- Regulatory filing and clinical trials
- Analytical reference standards and method development work by contract research organizations and formulation labs
- It is evaluated within peptide-adjacent research programs targeting cardiovascular peptide pathways.
Good to know: It functions by selectively blocking the AT1 receptor subtype. Pharmaceutical-grade specifications conform to USP, Ph. Eur. (EP), and BP monographs, supporting GMP-compliant manufacturing.
Commercial specifications
- Pharmaceutical-grade specifications conforming to USP, Ph. Eur. (EP), and BP monographs
- Quantities from research-scale lots to multi-kilogram commercial batches
- Documentation packages including CoA, DMF references, and impurity profiles available on request
Other Names (Synonyms)
VAL489|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine|Diovan|80M03YXJ7I